NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 41 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $26,634 | +23.8% | 102,440 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $21,512 | -17.3% | 102,440 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $26,000 | -64.9% | 102,440 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $74,000 | -8.6% | 102,440 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $81,000 | -20.6% | 102,440 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $102,000 | -43.0% | 102,440 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $179,000 | -4.3% | 102,440 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $187,000 | -54.3% | 102,440 | -49.4% | 0.00% | -62.5% |
Q1 2021 | $409,000 | +73.3% | 202,440 | +84.1% | 0.01% | +60.0% |
Q4 2020 | $236,000 | -34.1% | 109,940 | -17.1% | 0.01% | -37.5% |
Q3 2020 | $358,000 | +45.5% | 132,540 | +111.9% | 0.01% | +60.0% |
Q2 2020 | $246,000 | – | 62,540 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
UBS Group AG | 1,785 | $5,000 | 0.00% |